iPSC Technology for Huntington’s disease eBook

We’re excited to share our latest Huntington’s disease eBook, designed to empower researchers with cutting-edge tools and insights for advancing HD drug discovery.

Axol Bioscience provides a complete solution for Huntington’s disease research, offering iPSC-derived striatal neurons derived from patient and control iPSC lines and specialist assays and services for advanced in vitro modeling. Our capabilities include long-term instability studies, custom compound testing, and expert support in gene-editing, banking, and reprogramming, helping researchers accelerate discovery with physiologically relevant models.

In our new eBook, you will learn how Axol Bioscience is supporting HD research and drug development with iPSC-derived cell models, including sections on:

• Patient-derived iPSC lines and isogenic controls for physiologically relevant models
• axoCells™ human iPSC-derived striatal neurons for scalable in vitro studies
• Specialist assays and services to explore CAG repeat instability, neurite outgrowth, and hyperexcitability
• Longitudinal culture data supporting genomic instability studies
• Collaboration opportunities with Axol’s expert team

Whether you’re advancing drug discovery or researching the causes of HD, this is your essential guide to cutting-edge, physiologically relevant model systems.